GlassScriptPhysician profile
Salena Thomas
NPI 1144943473
$239.89
in general payments reported to CMS, 2019-2025
10 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $59.99 · 2024: $33.41 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $67.86 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $22.57 | 2025 | |
| Stryker Corporation | $22.43 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bayer Healthcare Pharmaceuticals INC. | $21.98 | 2025 | |
| Sumitomo Pharma America, INC. | $21.06 | 2023 | Myfembree |
| Astellas Pharma US INC | $20.55 | 2025 | Veozah |
| Dexcom, INC. | $20.07 | 2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $18.54 | 2025 | |
| Exeltis, USA INC. | $13.80 | 2023 | Slynd |
| Organon LLC | $11.03 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salena Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.